Manufacturers and congressional Republicans have criticized the agency for making it too hard for new drugs to reach the market. Medscape Medical News
No Comments »
Filed under: General Health News
Screening for hepatitis during colonoscopy visits could boost the diagnosis of hepatitis infection among baby boomers. Medscape Medical News
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — The FDA has raised the recall on a ventilator to class I — the agency’s most serious — because a defect can interrupt treatment and may cause neurological injury or death.
No Comments »
Filed under: General Health News
(MedPage Today) — Half of antibiotics given to children are broad-spectrum drugs, often with inappropriate indications, a national ambulatory care study found.
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — The FDA has raised the recall on a ventilator to class I — the agency’s most serious — because a defect can interrupt treatment and may cause neurological injury or death.
No Comments »
Filed under: Pharmacy News
Gilead Sciences, Inc. and the Cardiovascular Research Foundation (CRF) today announced the initiation of RIVER-PCI (Ranolazine for Incomplete VEssel Revascularization post-PCI), a Phase 3 clinical trial evaluating the utility of ranolazine to prevent major adverse cardiovascular events (MACE) in patients with a history of chronic angina who have incomplete revascularization following percutaneous coronary intervention (PCI).
No Comments »
Filed under: Pharmacy News
Baxter International Inc. today announced the presentation of its phase III study data for HyQ, an investigational combination immunoglobulin (IG) product for use in patients with primary immunodeficiencies (PI).
No Comments »
Filed under: Pharmacy News
NewCardio, Inc., a cardiovascular diagnostic solutions developer, announced today that a top 5 global pharmaceutical company has selected QTinno, their automated cardiac safety solution, for an upcoming Phase I drug safety study.
No Comments »
Filed under: Pharmacy News
ACADIA Pharmaceuticals Inc., a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced that the U.S. Food and Drug Administration has completed its review of ACADIA’s Investigational New Drug application to begin Phase I clinical studies with AM-831, an innovative small molecule [...]
No Comments »
Filed under: Pharmacy News
KYTHERA Biopharmaceuticals, Inc., a privately-held biotechnology company focused on the development and commercialization of prescription products in aesthetic medicine, presented results from a long-term follow up study assessing persistence of efficacy and post-treatment safety of ATX-101, a first-in-class, injectable drug that is under investigation for the reduction of submental fat.
No Comments »
Filed under: Pharmacy News
